Titolo	Data di pubblicazione	Autore(i)
1	Zinc supplementation improves glucose disposal in patients with cirrhosis.	1998	MARCHESINI G; E. BUGIANESI; RONCHI M; FLAMIA R; THOMASETH K; PACINI G
2	Which treatment for nonalcoholic fatty liver disease?	2008	Moscatiello S; Marzocchi R; Villanova N; Bugianesi E; Marchesini G.
3	Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study.	2011	Valenti L; Moscatiello S; Vanni E; Fracanzani AL; Bugianesi E; Fargion S; Marchesini G.
4	Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison.	1993	BIANCHI GP; MARCHESINI G; FABBRI A; RONDELLI A; E. BUGIANESI; ZOLI M; PISI E
5	A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-b1 dependent mechanisms	2019	Rasha El Sharkawy; Ali Bayoumi; Mayada Metwally; Alessandra Mangia; Thomas Berg; Manuel Romero-Gomez; Maria Lorena Abate; William L. Irving; David Sheridan; Gregory J. Dore; Ulrich Spengler; Pietro Lampertico; Elisabetta Bugianesi; Martin Weltman; Lindsay Mollison; Wendy Cheng; Stephen Riordan; Rosanna Santoro; Rocío Gallego-Durán; Janett Fischer; Jacob Nattermann; Roberta D’Ambrosio; Duncan McLeod; Elizabeth Powell; Olivier latchoumanin; Khaled Thabet; Mustafa A. M. Najim; Mark W. Douglas; Christopher Liddle; Liang Qiao; Jacob George; Mohammed Eslam
6	Validation of surrogate indexes of peripheral and hepatic insulin resistance and evaluation of their utility as non-invasive predictors of histological features in patients with Non-Alcoholic Fatty Liver Disease	2014	Chiara Rosso; Ester Vanni; Lavinia Mezzabotta; Roberto Gambino; Francesca Saba; Federico Salomone; Ramy Ibrahim Kamal Jouness; Melania Gaggini; Emma Buzzigoli; Chiara Saponaro; Fabrizia Carli; Gian Paolo Caviglia; Maria Lorena Abate; Antonina Smedile; Mario Rizzetto; Maurizio Cassader; Amalia Gastaldelli; Elisabetta Bugianesi
7	Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with Non-Alcoholic Fatty Liver: an external validation study	2018	Ramy, Younes; Chiara, Rosso; Salvatore, Petta; Monica, Cucco; Milena, Marietti; Gian Paolo Caviglia, ; Alessia, Ciancio; Maria Lorena Abate, ; Carlo, Cammà; Antonina, Smedile; Antonio, Craxì; Giorgio Maria Saracco, ; Elisabetta, Bugianesi
8	Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study	2017	Isokuortti, Elina; Zhou, You; Peltonen, Markku; Bugianesi, Elisabetta; Clement, Karine; Bonnefont-Rousselot, Dominique; Lacorte, Jean-Marc; Gastaldelli, Amalia; Schuppan, Detlef; Schattenberg, Jörn M.; Hakkarainen, Antti; Lundbom, Nina; Jousilahti, Pekka; Mã¤nnistã¶, Satu; Keinänen-Kiukaanniemi, Sirkka; Saltevo, Juha; Anstee, Quentin M.; Yki-Järvinen, Hannele
9	Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.	1993	FABBRI A ;MARCHESINI G ;BIANCHI G ;BUGIANESI E ;BORTOLUZZI L ;ZOLI M ;PISI E
10	Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure	1993	FABBRI A; MARCHESINI G; BIANCHI G; E. BUGIANESI; BORTOLUZZI L; ZOLI M; PISI E
11	Undernutrition, risk of malnutrition and obesity in gastroenterological patients: A multicenter study	2016	Rizzi, Massimiliano; Mazzuoli, Silvia; Regano, Nunzia; Inguaggiato, Rosa; Bianco, Margherita; Leandro, Gioacchino; Bugianesi, Elisabetta; Noè, Donatella; Orzes, Nicoletta; Pallini, Paolo; Petroni, Maria Letizia; Testino, Gianni; Guglielmi, Francesco William
12	Unconjugated Bilirubin, A Potent Endogenous Antioxidant, is Decreased in Patients with Nonalcoholic Steatohepatitis and Advanced Fibrosis.	2013	Salomone F;Volti GL;Rosso C;Grosso G;Bugianesi E
13	Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study.	2012	Giordanino C; Ceretto S; Bo S; Smedile A; Ciancio A; Bugianesi E; Pellicano R;Fagoonee S; Versino E; Costa G; Arese D; Sacco M; Rizzetto M; Saracco G.
14	Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: mith or reality?	2016	Vanni, Ester; Bugianesi, Elisabetta; Saracco, Giorgio
15	Transamination of methionine after loading in patients with cirrhosis.	1996	BUGIANESI E ;TANGERMAN A ;RONCHI M ;BIANCHI G ;MARCHESINI G
16	The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study	2011	Neeraj Bhala; Paul Angulo; David van der Poorten; Eric Lee; Jason M. Hui; Giorgio Saracco; Leon A. Adams; Phunchai Charatcharoenwitthaya; Joanne H. Topping; Elisabetta Bugianesi; Christopher P. Day; Jacob George
17	The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.	2007	ANGULO P ;HUI JM ;MARCHESINI G ;BUGIANESI E ;GEORGE J ;FARRELL GC ;ENDERS F ;SAKSENA S ;BURT AD ;BIDA JP ;LINDOR K ;SANDERSON SO ;LENZI M ;ADAMS LA ;KENCH J ;THERNEAU TM ;DAY CP
18	The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD	2007	ANGULO P; HUI JM; MARCHESINI G; E. BUGIANESI; GEORGE J; FARRELL GC; ENDERS F; SAKSENA S; BURT AD; BIDA JP; LINDOR K; SANDERSON SO; LENZI M; ADAMS LA; KENCH J; THERNEAU TM; DAY CP
19	The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease	2008	Miele L; Beale G; Patman G; Nobili V; Leathart J; Grieco A; Abate M; Friedman SL; Narla G; Bugianesi E; Day CP; Reeves HL.
20	The interaction of metabolic factors with HCV infection: Does it matter?	2012	Bugianesi E; Salamone F; Negro F.